条状胆固醇内神经元的同步激活会诱导局部的血清释放
Lior Matityahu1, Zachary B Hobel2, Noa Berkowitz1
1Department of Medical Neurobiology, Institute of Medical Research Israel - Canada, Faculty of the Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Nature communications
|March 17, 2026
概括
条状胆固醇内神经元 (CINs) 的同步激活会通过尼古丁性乙胆受体 (nAChRs) 触发脊椎条状体中的血清素释放. 在强迫症模型中,这种机制被夸大了.
科学领域:
- 神经科学是一个神经科学.
- 神经化学 神经化学
背景情况:
- 状胆固醇内部神经元 (CINs) 通过尼古丁乙胆受体 (nAChRs) 在多巴胺基轴突上调节多巴胺释放.
- 在调节血清素 (5-HT) 信号传递方面,CINs的作用仍然基本未知.
研究的目的:
- 调查CIN激活对状体中5-HT信号传递的直接影响.
- 为了确定CIN介导的5-HT释放的区域特异性和受体依赖性.
- 在痴迷强迫症 (OCD) 的小鼠模型中探索这种途径的变化.
主要方法:
- 电生理学记录和药理学操纵在小鼠的条状切片.
- 在体内微透析以测量神经递质释放.
- 对Sapap3淘汰赛小鼠的行为分析.
主要成果:
- 同步的CIN激活直接诱导背上条纹体中通过nAChRs在血清激素轴突上的局部5-HT释放.
- 这种CIN-5-HT合是特定区域的,在腹状条纹体中不存在.
- 依赖nAChR的5-HT释放增强了5-HT水平,并扩大了其在背状体的信号范围.
- 在Sapap3-/-小鼠中,高胆能状态夸大了这种途径,放大了nAChR依赖的单胺释放.
结论:
- 在状体内,CINs以特定区域的方式作为5-HT动态的调节者.
- 通过nAChRs的乙胆 - 血激素交叉是影响条状神经传递的关键机制.
- 这一途径在强迫症类状态中是失调的,这表明它是一个潜在的治疗目标.
更多相关视频
相关概念视频
Cholinergic Neurons: Neurotransmission
6.0K
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
6.0K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
1.2K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.2K
Drugs Affecting Neurotransmitter Release or Uptake
1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Adrenergic Agonists: Indirect-Acting Agents
3.0K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
3.0K
Neurochemical Transmission: Sites of Drug Action
3.9K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.9K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.9K


